Home health issue Press Release: Dupixent® (dupilumab) approved by European Commission as first and only targeted medicine for children as young as six months old with severe atopic dermatitis

Press Release: Dupixent® (dupilumab) approved by European Commission as first and only targeted medicine for children as young as six months old with severe atopic dermatitis

Rita rai March 21, 2023 Add Comment health issue Edit

https://ift.tt/HlWkNU8

Dupixent^® (dupilumab) approved by European Commission as first and only targeted medicine for children as young as six months old with severe atopic dermatitis

from Sanofi - Aventis Groupe https://ift.tt/V04vUlK
via IFTTT

from health care https://ift.tt/rMKgY15
via IFTTT https://ift.tt/tNyI1dp

Milan Tomic

Hi. I’m Designer of Blog Magic. I’m CEO/Founder of ThemeXpose. I’m Creative Art Director, Web Designer, UI/UX Designer, Interaction Designer, Industrial Designer, Web Developer, Business Enthusiast, StartUp Enthusiast, Speaker, Writer and Photographer. Inspired to make things looks better.